AMPHASTAR PHARMACEUTICALS IN (AMPH)
US03209R1032 - Common Stock
| TTM (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 154.74M | 137.54M | 91.39M | 63.30M | 1.10M | |||
| Depreciation Amortization | 44.52M | 38.03M | 25.24M | 23.49M | 21.53M | |||
| Income Taxes - Deferred | N/A | -12.58M | -16.45M | 2.39M | -160.00K | |||
| Change In Working Capital | -31.37M | -24.21M | -32.18M | -1.92M | 9.13M | |||
| Interest Paid | 25.00M | 17.57M | 3.02M | 2.11M | 2.20M | |||
| Taxes Paid | 49.05M | 49.00M | 44.44M | 8.10M | 3.41M | |||
| Other non cash items | 43.11M | 44.71M | 21.18M | 10.74M | 25.68M | |||
| OPERATING CASH FLOW | 198.39M | 183.50M | 89.18M | 97.99M | 57.27M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -37.46M | -38.17M | -24.03M | -27.46M | -33.86M | |||
| Other Investing Activity | -590.02M | -610.95M | -8.74M | -1.22M | -2.56M | |||
| INVESTING CASH FLOW | -627.58M | -649.12M | -32.78M | -28.67M | -36.42M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 531.33M | 526.34M | -1.78M | 32.10M | -880.00K | |||
| Stock Issued/Repurchased | -51.88M | -47.17M | -24.25M | -12.95M | -1.26M | |||
| Other Financing Activity | -25.33M | -25.08M | -410.00K | -56.17M | -110.00K | |||
| FINANCING CASH FLOW | 454.01M | 454.09M | -26.44M | -37.02M | -2.25M | |||
| Exchange Rate Effect | -379.00K | -282.00K | -220.00K | -220.00K | 350.00K | |||
| CHANGE IN CASH | 24.45M | -11.80M | 29.74M | 32.08M | 18.95M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 198.39M | 183.50M | 89.18M | 97.99M | 57.27M | |||
| Capital Expenditure | -37.46M | -38.17M | -24.03M | -27.46M | -33.86M | |||
| FREE CASH FLOW | 160.94M | 145.34M | 65.15M | 70.53M | 23.41M | |||
All data in USD